MRNA SG&A Expense Growth

Moderna · SG&A Expense Growth

MRNA logo

MRNA SG&A Expense Growth

Latest reported-13.29%
MRNA FY SG&A Growth (YoY) (0.00% → -13.29%)
High-resolution chart · PNG

MRNA sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
-13.2879%
-24.2092%
36.8375%
99.6473%
201.168%
71.7451%
16.3052%
45.6259%
12.658%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.